Literature DB >> 15814398

Follicle tracking of women receiving clomiphene citrate for ovulation induction.

T Giannopoulos1, E Sherriff, Carolyn Croucher.   

Abstract

Forty-five cycles of forty subfertile women were monitored with follicle tracking. Thirty women were anovulatory and 10 had unexplained infertility. Thirty women responded to the initial dose of Clomiphene Citrate (CC) and 10 remained anovulatory. Of those who ovulated with the first dose of CC, 25 developed one follicle, 2 developed 2 follicles and 3 developed three follicles. All the women that produced three follicles belonged in the unexplained infertility group. Eight women from the anovulatory group developed 1 follicle, two developed 2 follicles and 8 failed to respond. Provision of universal follicle tracking proved to be time consuming and required significant resources. Our results indicate that if there is a place for selective monitoring that should include women with unexplained infertility. We should also offer the first scan at around day 12 of the cycle as this could detect multiple follicle development. Patients with Polycystic Ovaries that start on 50 mgs of CC may not necessarily need follicle tracking as they usually do not respond to that dose.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814398     DOI: 10.1080/01443610500041073

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Effect of luteinized unruptured follicle cycles on clinical outcomes of frozen thawed embryo transfer in Chinese women.

Authors:  Lina Wang; Jie Qiao; Ping Liu; Ying Lian
Journal:  J Assist Reprod Genet       Date:  2008-06-20       Impact factor: 3.412

2.  Fertility management in the PCOS population: results of a web-based survey at IVF-worldwide.com.

Authors:  Paul R Brezina; Virginia Mensah; Adam Balen; Milton Leong; Ariel Weissman; Yulian Zhao; Zeev Shoham
Journal:  J Assist Reprod Genet       Date:  2013-07-30       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.